PortfoliosLab logo

Amphastar Pharmaceuticals, Inc. (AMPH)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Amphastar Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $41,474 for a total return of roughly 314.74%. All prices are adjusted for splits and dividends.


0.00%10.00%20.00%30.00%NovemberDecember2023FebruaryMarch
27.78%
6.48%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AMPH

Amphastar Pharmaceuticals, Inc.

Return

Amphastar Pharmaceuticals, Inc. had a return of 29.51% year-to-date (YTD) and 6.05% in the last 12 months. Over the past 10 years, Amphastar Pharmaceuticals, Inc. had an annualized return of 17.72%, outperforming the S&P 500 benchmark which had an annualized return of 8.27%.


PeriodReturnBenchmark
1 month12.11%-5.31%
Year-To-Date29.51%2.01%
6 months23.73%0.39%
1 year6.05%-10.12%
5 years (annualized)12.77%7.32%
10 years (annualized)17.72%8.27%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20237.99%5.29%
2022-5.07%9.96%-4.56%-4.98%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Amphastar Pharmaceuticals, Inc. Sharpe ratio is 0.13. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00NovemberDecember2023FebruaryMarch
0.13
-0.43
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Amphastar Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%NovemberDecember2023FebruaryMarch
-14.19%
-18.34%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Amphastar Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amphastar Pharmaceuticals, Inc. is 49.92%, recorded on Mar 20, 2020. It took 456 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-49.92%Mar 4, 2019266Mar 20, 2020456Jan 10, 2022722
-43.39%Nov 18, 201678Mar 14, 2017420Nov 9, 2018498
-42.11%Jun 26, 2015170Feb 29, 2016115Aug 11, 2016285
-35.49%Apr 14, 2022144Nov 8, 2022
-20.08%Sep 21, 201632Nov 3, 201610Nov 17, 201642
-18.81%Sep 11, 201444Nov 11, 201418Dec 8, 201462
-17.24%Jun 30, 20148Jul 10, 201432Aug 25, 201440
-15.42%Dec 4, 201814Dec 24, 201819Jan 23, 201933
-12.25%Aug 24, 201614Sep 13, 20165Sep 20, 201619
-11.5%Jan 8, 20156Jan 15, 201513Feb 4, 201519

Volatility Chart

Current Amphastar Pharmaceuticals, Inc. volatility is 33.07%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%20.00%40.00%60.00%80.00%NovemberDecember2023FebruaryMarch
33.07%
21.17%
AMPH (Amphastar Pharmaceuticals, Inc.)
Benchmark (^GSPC)